Idenix Pharmaceuticals Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
65
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$3.9B
Idenix Pharmaceuticals General Information
Description
Operator of a biopharmaceutical company engaged in the discovery and development of drugs to treat human viral diseases. The company utilizes its specialties in nucleoside chemistry and other small molecule chemistries to develop antiviral pharmaceuticals. The company's current focus is on the treatment of patients with hepatitis C infection.
Contact Information
Corporate Office
- 60 Hamphire Street
- Cambridge, MA 02139
- United States
Corporate Office
- 60 Hamphire Street
- Cambridge, MA 02139
- United States
Idenix Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 05-Aug-2014 | $3.9B | Completed | Generating Revenue | ||
| 8. PIPE | 28-Jan-2014 | Completed | Generating Revenue | |||
| 7. 2PO | 26-Oct-2005 | Completed | Generating Revenue | |||
| 6. 2PO | 25-Oct-2005 | Completed | Generating Revenue | |||
| 5. IPO | 22-Jul-2004 | Completed | Generating Revenue | |||
| 4. IPO | 16-Dec-2002 | Cancelled | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 01-Jun-2001 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 01-Aug-1999 | $12.4M | $24.6M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-Jun-1998 | $12.3M | $12.3M | Completed | Product Development |
Idenix Pharmaceuticals Comparisons
Industry
Financing
Details
Idenix Pharmaceuticals Competitors (20)
One of Idenix Pharmaceuticals’s 20 competitors is Gilead, a Formerly VC-backed company based in Foster City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| BioCryst Pharmaceuticals | Corporation | Durham, NC | ||||
| Innate Pharma | Formerly VC-backed | Marseille, France | ||||
| Astellas Pharma | Corporation | Tokyo, Japan | ||||
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom |
Idenix Pharmaceuticals Signals
Idenix Pharmaceuticals Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adage Capital Management | Hedge Fund | Minority | ||
| BB Biotech | Asset Manager | Minority | ||
| Bank of America | Investment Bank | Minority | ||
| Brookside Capital | Venture Capital | Minority | ||
| Credit Suisse | Investment Bank | Minority |
Idenix Pharmaceuticals FAQs
-
When was Idenix Pharmaceuticals founded?
Idenix Pharmaceuticals was founded in 1998.
-
Where is Idenix Pharmaceuticals headquartered?
Idenix Pharmaceuticals is headquartered in Cambridge, MA.
-
What is the size of Idenix Pharmaceuticals?
Idenix Pharmaceuticals has 65 total employees.
-
What industry is Idenix Pharmaceuticals in?
Idenix Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Idenix Pharmaceuticals a private or public company?
Idenix Pharmaceuticals is a Private company.
-
What is the current valuation of Idenix Pharmaceuticals?
The current valuation of Idenix Pharmaceuticals is .
-
What is Idenix Pharmaceuticals’s current revenue?
The current revenue for Idenix Pharmaceuticals is .
-
How much funding has Idenix Pharmaceuticals raised over time?
Idenix Pharmaceuticals has raised $576M.
-
Who are Idenix Pharmaceuticals’s investors?
Adage Capital Management, BB Biotech, Bank of America, Brookside Capital, and Credit Suisse are 5 of 16 investors who have invested in Idenix Pharmaceuticals.
-
Who are Idenix Pharmaceuticals’s competitors?
Gilead, BioCryst Pharmaceuticals, Innate Pharma, Astellas Pharma, and Immunocore Holdings are some of the 20 competitors of Idenix Pharmaceuticals.
-
When was Idenix Pharmaceuticals acquired?
Idenix Pharmaceuticals was acquired on 05-Aug-2014.
-
Who acquired Idenix Pharmaceuticals?
Idenix Pharmaceuticals was acquired by Merck & Co..
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process